Page 69 - 77_01
P. 69

GUZMÁN-­-ARANGUREN	
  Y	
  COLS	
  
	
  

negative	
  control	
  to	
  prove	
  that	
  silencing	
  of	
  the	
  gene	
  of	
  interest	
  is	
  due	
  to	
  specificity	
  
of	
  siRNA	
  and	
  is	
  not	
  due	
  to	
  non-­-specific	
  effects.	
  

Table	
  1.	
  Small	
  interfering	
  RNAs	
  (siRNAs)	
  sequences.	
  

      siRNAs	
      Sense	
  (5´-­-3´)	
                   Anti-­-sense	
  (5´-­-3´)	
  

      SEQ	
  1	
    CCGUAGCCGUGAAGAUGCUTT	
                AGCAUCUUCACGGCUACGGTG	
  
      SEQ	
  2	
    CCUGCGUCGUGGAGAACAATT	
                UUGUUCUCCACGACGCAGGTG	
  

      SEQ	
  3	
    AGGUGUACAGUGACGCACATT	
                UGUGCGUCACUGUACACCUTG	
  

	
  

      Transfection	
  complexes	
  were	
  prepared	
  in	
  an	
  Opti-­-MEM	
  serum	
  free	
  medium	
  

(Invitrogen)	
   by	
   mixing	
   7	
   µl	
   of	
   siPORT	
   NeoFX	
   transfection	
   reagent	
   (Applied	
  
Biosystems)	
   and	
   300	
   nM	
   of	
   scramble/FGFR3	
   siRNAs.	
   Inmortalized	
   human	
  
chondrocytes	
  carrying	
  the	
  achondroplasia	
  mutation	
  were	
  platted	
  in	
  a	
  6	
  well	
  plate	
  

after	
   the	
   addition	
   of	
   transfection	
   complexes.	
   After	
   72h,	
   RNA	
   and	
   protein	
   were	
  

isolated	
  to	
  analyze	
  knockdown	
  efficiency.	
  

2.3.	
  Reverse	
  Transcriptase-­-PCR	
  

        Total	
   RNA	
   was	
   extracted	
   from	
   the	
   achondroplastic	
   chondrocytes	
   using	
   the	
  
Nucleospin	
   RNA/Protein	
   Kit	
   (Macherey-­-Nagel,	
   Düren,	
   Germany)	
   according	
   to	
   the	
  

instructions	
   of	
   the	
   manufacturer	
   and	
   1	
   µg	
   was	
   reverse	
   transcribed	
   using	
  
SuperScript	
  III	
  First-­-Strand	
  synthesis	
  system	
  Kit	
  (Invitrogen).	
  

        The	
   FGFR3-­-specific	
   primers	
   (forward	
   5'-­-	
   TGCTGAATGCCTCCCACG	
   -­-3'	
   and	
  
reverse	
  5'-­-	
  CCAGGCTCCACTGCTGATG	
  -­-3')	
  that	
  have	
  been	
  previously	
  described	
  (11,	
  
12)	
   were	
   employed	
   for	
   amplification	
   of	
   FGFR3.	
   Glyceraldehyde-­-3	
   phosphate	
  
dehydrogenase	
   (GAPDH)	
   was	
   used	
   as	
   an	
   internal	
   control	
   and	
   GAPDH-­-specific	
  
primers	
   (forward	
   5'-­-	
   ACCACAGTCCATGCCATCAC	
   -­-3'	
   and	
   reverse	
   5'-­-	
  
TCCACCACCCTGTTGCTGTA	
   -­-3')	
   were	
   purchased	
   from	
   Clontech	
   (Clontech,	
  
Mountain	
   View,	
   CA,	
   USA).	
   Reactions	
   were	
   performed	
   using	
   TITANUM	
   Taq	
   DNA	
  
polymerase	
   (Clontech).	
   For	
   FGFR3	
   amplification,	
   reactions	
   conditions	
   were	
   94	
   °C	
  
for	
  3	
  minutes,	
  followed	
  by	
  35	
  cycles	
  at	
  94	
  °C	
  for	
  1	
  minute,	
  60	
  °C	
  for	
  1	
  minute,	
  and	
  
72	
   °C	
   for	
   10	
   minutes.	
   The	
   thermal	
   cycling	
   conditions	
   for	
   GAPDH	
   amplification	
  
were	
  94	
  °C	
  for	
  5	
  minutes,	
  followed	
  by	
  30	
  cycles	
  at	
  94	
  °C	
  for	
  45	
  seconds,	
  60	
  °C	
  for	
  
45	
  seconds,	
  72	
  °C	
  for	
  2	
  minutes	
  and	
  72	
  °C	
  for	
  7	
  minutes.	
  

        PCR	
   products	
   were	
   electrophoresed	
   on	
   1.5%	
   agarose	
   gel,	
   stained	
   by	
  
ethidium	
  bromide	
  and	
  quantified	
  using	
  a	
  Kodak	
  GL	
  200	
  Imaging	
  system	
  and	
  Kodak	
  
Molecular	
  Imaging	
  software	
  (Kodak,	
  Rochester,	
  NY,	
  USA).	
  The	
  values	
  of	
  the	
  ratio	
  of	
  
FGFR3	
   to	
   GAPDH	
   were	
   calculated	
   and	
   normalized	
   by	
   scramble	
   control	
   when	
   the	
  
value	
  of	
  scramble	
  control	
  was	
  defined	
  as	
  100%.	
  

2.4.	
  Western	
  Blot	
  Analysis	
  

        Total	
   protein	
   from	
   achondroplastic	
   chondrocytes	
   transfected	
   with	
   the	
  
siRNAs	
  were	
  isolated	
  using	
  the	
  Nucleospin	
  RNA/Protein	
  Kit	
  (Macherey-­-Nagel)	
  and	
  
protein	
   concentration	
   was	
   determined	
   by	
   the	
   Protein	
   Quantification	
   assay	
  
(Macherey-­-Nagel).	
  

6
   64   65   66   67   68   69   70   71   72   73   74